新聞Sanofi partners with Kadmon Holdings, Inc..Sanofi announced that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging its proprietary, clinically validated XTEN® and innovative universal protease-releasable masking technology platform, Pro-XTENTM, to discover and develop tra ... more Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs.
新聞Carver left Kadmon Holdings, Inc. as chief accounting officer on Feb 22nd '22.Mr. Carver joins Evommune from Kadmon Holdings, Inc., a Sanofi Company, where he served in various roles, most recently as chief accounting officer.
新聞Kadmon Holdings, Inc. partnered with Party Animalz Entertainment Llc on Jul 28th '21.Meanwhile, Kadmon had entered a confidentiality agreement with standstill provisions with Party A, which during a meeting at its European headquarters on July 28, indicated that it was also interested in acquiring the New York biotech.
